-
Something wrong with this record ?
Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study
Otto Hrodek
Transfuze a hematologie dnes.
2014 ;
20 (2) :
86-87.
Language Czech Country Czech Republic
Document type Overall
Persistent link
https://www.medvik.cz/link/bmc14076851
Digital library NLK
Volume
Source
NLK
ROAD: Directory of Open Access Scholarly Resources
from 2000
- Keywords
- imatinib,
- MeSH
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive * drug therapy MeSH
- Dasatinib MeSH
- Protein Kinase Inhibitors pharmacology MeSH
- Clinical Trials, Phase III as Topic MeSH
- Humans MeSH
- Survival MeSH
- Randomized Controlled Trials as Topic MeSH
- Protein-Tyrosine Kinases * antagonists & inhibitors pharmacology MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Overall MeSH
Citace: Neil P. Shah, François Guilhot, Jorge E. Cortes, et al., Blood 10 April 2014, Vol. 123, No. 15, pp. 2317-2324.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14076851
- 003
- CZ-PrNML
- 005
- 20141111130054.0
- 007
- ta
- 008
- 141024s2014 xr f 000 0|cze||
- 009
- PC
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a cze
- 044 __
- $a xr
- 100 1_
- $a Hrodek, Otto, $d 1922-2022 $7 jk01042803
- 245 10
- $a Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study / $c Otto Hrodek
- 500 __
- $a Citace: Neil P. Shah, François Guilhot, Jorge E. Cortes, et al., Blood 10 April 2014, Vol. 123, No. 15, pp. 2317-2324.
- 650 12
- $a chronická myeloidní leukemie $x farmakoterapie $7 D015464
- 650 _2
- $a výsledek terapie $7 D016896
- 650 12
- $a tyrosinkinasy $x antagonisté a inhibitory $x farmakologie $7 D011505
- 650 _2
- $a inhibitory proteinkinas $x farmakologie $7 D047428
- 650 _2
- $a přežití $7 D013534
- 650 _2
- $a randomizované kontrolované studie jako téma $7 D016032
- 650 _2
- $a klinické zkoušky, fáze III jako téma $7 D017326
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a dasatinib $7 D000069439
- 653 0_
- $a imatinib
- 655 _2
- $a souhrny $7 D016424
- 773 0_
- $w MED00012579 $t Transfuze a hematologie dnes $x 1213-5763 $g Roč. 20, č. 2 (2014), s. 86-87
- 856 41
- $u https://www.prolekare.cz/casopisy/transfuze-hematologie-dnes/2014-2/hrodek-o-long-term-outcome-with-dasatinib-after-imatinib-failure-in-chronic-phase-chronic-myeloid-leukemia-follow-up-of-a-phase-3-study-49997 $y plný text volně dostupný
- 910 __
- $a ABA008 $b B 1935 $c 322 a $y 4 $z 0
- 990 __
- $a 20141024 $b ABA008
- 991 __
- $a 20141111130106 $b ABA008
- 999 __
- $a ok $b bmc $g 1045220 $s 875804
- BAS __
- $a 6
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 20 $c 2 $d 86-87 $i 1213-5763 $m Transfuze a hematologie dnes $x MED00012579 $y 75040
- LZP __
- $c NLK183 $d 20141111 $b NLK118 $a Meditorial-20141024
